SANDOSTATIN LAR - Home - HCP

What is Sandostatin® LAR® (octreotide acetate) used for?

SANDOSTATIN LAR is indicated for the treatment of:

  • Patients with symptoms associated with functional gastro-entero-pancreatic endocrine tumours (e.g. carcinoid tumours with features of the carcinoid syndrome) or patients with advanced neuroendocrine tumours of the midgut or of unknown primary origin where non-midgut sites of origin have been excluded1

  • Patients with acromegaly in whom surgery is inappropriate or ineffective, or in the interim period until radiotherapy becomes fully effective1

  • Patients with TSH-secreting pituitary adenomas:1

    • when secretion has not normalised after surgery and/or radiotherapy

    • in patients in whom surgery is inappropriate

    • in irradiated patients, until radiotherapy is effective.


Resources for you:

Image
Preview image. Reconstitution and preparation of SANDOSTATIN LAR guide for HCPs.

Reconstitution and preparation of SANDOSTATIN LAR

PDF

Reconstitution and preparation of SANDOSTATIN LAR

A guide on how to prepare and administer SANDOSTATIN LAR.

Preview image. How to administer and prepare to SANDOSTATIN LAR video.

How to administer and prepare SANDOSTATIN LAR

A step-by-step video on how to prepare and administer SANDOSTATIN LAR.


Resources for your patients:

Image
Preview image. Your guide to SANDOSTATIN LAR.

SASLAR - Home - patient guide - resource card

PDF

Your guide to SANDOSTATIN LAR

A guide to help you understand the treatment options you may be offered with SANDOSTATIN LAR.


Sandostatin LAR SmPC

TSH, thyroid-stimulating hormone.

 

Reference

  1. SANDOSTATIN® LAR® Summary of Product Characteristics.

UK | February 2025 | FA-11214504

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.


Source URL: https://www.pro.novartis.com/uk-en/medicines/oncology/sandostatin-lar